Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics

Allen R. Nissenson, Nathan W. Levin, Richard H. Parker

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Cephacetrile, a new injectable cephalosporin antibiotic that is allegedly not nephrotoxic, was evaluated in 15 subjects with varying degrees of renal functional impairment. Cephacetrile has a serum half-life of 1.3 hours in normal subjects which depends on the glomerular filtration rate. The total plasma clearance rate and the renal clearance rate of cephacetrile are high compared with the clearance rates of other cephalosporins, so also is the fraction of the injected dose excreted in the urine. Renal excretion of cephacetrile is accomplished by glomerular filtration and tubular secretion in normal subjects, but in patients with renal failure there is little evidence of tubular secretion. Cephacetrile is partially dialyzable, but higher serum levels during hemodialysis are noted after a standard dose than are expected after a similar dose of cephalothin or cephaloridine.

Original languageEnglish
Pages (from-to)887-894
Number of pages8
JournalClinical Pharmacology and Therapeutics
Volume13
Issue number6
DOIs
StatePublished - 1972
Externally publishedYes

Fingerprint

Dive into the research topics of 'Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics'. Together they form a unique fingerprint.

Cite this